Biogen | Créances Commerciales



Trade Debtors Changement Date
AbbVie USD 10.92B 553M 2024-12
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
ALKERMES USD 321.75M 72.97M 2025-03
Amgen USD 8.13B 1.35B 2025-03
Bayer EUR 12.5B 1.33B 2024-12
Biogen USD 2B 127.7M 2025-03
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Eli Lilly USD 14B 727.8M 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
Incyte USD 823.13M 30.02M 2025-03
Merck USD 11.57B 452M 2025-03
Moderna USD 306M 286M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Pfizer USD 14.74B 32M 2025-03
PTC Therapeutics USD 158.55M 41.42M 2024-12
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Sanofi 447M 10.18B 2025-03
Sanofi 10.63B 1.82B 2024-12
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Teva Pharmaceutical Industries USD 3.06B 403M 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
United Therapeutics USD 322M 42.7M 2025-03
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Biogen Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.